ArticleJournal of translational medicine2026
Urothelial Piezo1 channel contributes to BOO-induced inflammation, EMT, and bladder fibrosis via activation of NLRP3 inflammasome.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biomechanical regulation of bladder injury and repair.Nature reviews. Urology · 2026Review
- The role of Piezo1 as a mechanotransduction hub in bladder fibrosis: therapeutic targeting strategies and challenges-a narrative review.Translational andrology and urology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundElevated intravesical pressure has been implicated as a key trigger in the onset and progression of bladder outlet obstruction (BOO)-induced inflammation and fibrosis. Mechanosensitive ion channel Piezo1 is abundantly expressed in urothelium. However, it remains unclear whether Piezo1 in the bladder epithelium is necessary for BOO-induced fibrosis. This study aimed to elucidate the role of urothelial Piezo1 in BOO-induced bladder fibrosis.
methodsBOO was induced in female mice via partial urethral ligation. Urothelium-specific Piezo1 conditional knockout mice and Piezo1-knockout human urothelial cell line (SV-HUC-1) were used to investigate Piezo1 function in vivo and in vitro, respectively. Fibrosis was assessed using Masson’s trichrome staining and by evaluating protein expression levels of collagen I, fibronectin, and epithelial-to-mesenchymal transition (EMT) markers (α-SMA, N-cadherin, and E-cadherin).
resultsWe observed that BOO was associated with mucosal fibrosis in both benign prostatic hyperplasia patients and BOO mice. Additionally, BOO induced upregulation of Piezo1, NLRP3 inflammasome, Caspase-1, IL-1β, and EMT markers (α-SMA, N-cadherin) in urothelial cells from both human and mouse. Notably, these changes were significantly attenuated in urothelial Piezo1-knockout mice. In vitro, pathological cyclic pressure stimulation (100 cmH₂O for 5 minutes every 2 hours over 24 hours) led to increased expression of NLRP3, Caspase-1, IL-1β, EMT markers, and profibrotic changes in SV-HUC-1 cells. These pressure-induced changes were markedly reduced in Piezo1-knockout cells. Mechanistically, Piezo1 activation under high pressure leads to several cellular events such as intracellular Ca2 + increase, ATP release, ROS generation, and NF-κB activation, culminating in NLRP3 activation.
conclusionsOur findings suggest that Piezo1 contributes to BOO induced inflammation and fibrosis, and targeting Piezo1 represent a novel strategy for treatment of bladder fibrosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.